1. A meta-analysis of the association between BRAF mutation and nonsmall cell lung cancer
   Guanghui Cui et al, 2017, Medicine CrossRef
2. Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma
   Chenyue Zhang et al, 2022, Frontiers in Oncology CrossRef
3. Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis
   Teppei Yamaguchi et al, 2024, BMC Cancer CrossRef
4. A highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening
   Jrhau Lung et al, 2020, Scientific Reports CrossRef
5. Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma
   Ling Shan et al, 2015, PLOS ONE CrossRef
6. Dietary Risk Factors and Odds of Colorectal Adenoma in Malaysia: A Case Control Study
   Razinah Sharif et al, 2022, Nutrition and Cancer CrossRef
7. Detection of EGFR and BRAF mutations by competitive allele-specific TaqMan polymerase chain reaction in lung adenocarcinoma
   Yang Yang et al, 2017, Oncology Letters CrossRef
8. Comparison of CT radiogenomic and clinical characteristics between EGFR and KRAS mutations in lung adenocarcinomas
   J. Lv et al, 2018, Clinical Radiology CrossRef
9. Increased BRAF copy number in lung adenocarcinoma
   HIDEFUMI SASAKI et al, 2015, Oncology Letters CrossRef
10. The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC
    Yang Yang et al, 2017, Oncotarget CrossRef
11. Intra-tumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas
    TSUTOMU TATEMATSU et al, 2015, Experimental and Therapeutic Medicine CrossRef
12. BRAF Mutations in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Dong Chen et al, 2014, PLoS ONE CrossRef
13. Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in Japanese lung adenocarcinoma
    Hidefumi Sasaki et al, 2013, Lung Cancer CrossRef
14. Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience
    Arjun Khunger et al, 2018, Therapeutic Advances in Respiratory Disease CrossRef
15. A literature review of a meta-analysis of BRAF mutations in non-small cell lung cancer
    Clint Taonaishe Chimbangu et al, 2024, Medicine CrossRef
16. Targeting of MEK in lung cancer therapeutics
    David F Heigener et al, 2015, The Lancet Respiratory Medicine CrossRef
17. Clinical Characteristics, Co-Mutations, and Treatment Outcomes in Advanced Non-Small-Cell Lung Cancer Patients With the BRAF-V600E Mutation
    Jingjing Qu et al, 2022, Frontiers in Oncology CrossRef
18. A Case of Left Ventricular Contractile Dysfunction with Complete Atrioventricular Block During Administration of Dabrafenib Plus Trametinib in Which Treatment Was Able to Be Continued with Dabrafenib Alone
    Ryusaku Hosoya et al, 2023, Haigan CrossRef